Completed PHASE3 INTERVENTIONAL 3-arm NCT00712920

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies

Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 and MP03-33 in Patients With Perennial Allergic Rhinitis

Sponsor: Meda Pharmaceuticals

Conditions Perennial Allergic Rhinitis

Interventions 0.1% azelastine hydrochloride 0.15% azelastine hydrochloride Placebo

Updated 8 times since 2017 Last updated: Jun 6, 2011 Started: Jan 31, 2007 Primary completion: May 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Perennial Allergic Rhinitis and is currently completed. Meda Pharmaceuticals leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Meda Pharmaceuticals

Data source: Meda Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Charleston, United States , Cincinnati, United States , Collegeville, United States , Colorado Springs, United States , Colorodo Springs, United States , Dallas, United States , Henderson, United States , Huntington Beach, United States , Lake Oswego, United States and 28 more locations